Editing of hemoglobin gene leads two people with different conditions to no longer need regular blood transfusions.
Company claims signs of success with CRISPR-edited stem cell transplants for two genetic diseases
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
Editing of hemoglobin gene leads two people with different conditions to no longer need regular blood transfusions.